MedTrace Logo

A Message Framing Intervention for Increasing Parental Acceptance of Human Papillomavirus Vaccination

NCT03856437 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1170

Last updated 2024-03-15

Study results available
· View outcomes & findings →

Summary

The goal of this study is to determine the effects of message framing (gain vs. loss) on African American parents' acceptance of the HPV vaccine and how such effects are moderated by parents' salient beliefs prior to message exposure. Participants are randomized into gain and loss conditions in which they view either gain-framed or loss-framed HPV vaccination messages. Key outcome variables include parents' attitudes and intentions toward vaccinating their children against HPV.

Conditions

Interventions

BEHAVIORAL

HPV vaccination messages

Digital multimedia messages consisting of text and imagery conveying the benefits of being vaccinated against HPV, the costs of not being vaccinated against HPV, or neither benefits or costs but simply a call for action.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • University of Maryland, College Park

    lead OTHER

Principal Investigators

  • Xiaoli Nan · University of Maryland, College Park

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-22
Primary Completion
2021-03-25
Completion
2022-04-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03856437 on ClinicalTrials.gov